Risk factors for positive paracetamol drug provocation testing and procedure optimization

J Allergy Clin Immunol Pract. 2019 Jul-Aug;7(6):2045-2048.e2. doi: 10.1016/j.jaip.2019.01.031. Epub 2019 Jan 29.

¹ Department of Pulmonology, Division of Allergy, Hôpital Arnaud de Villeneuve, University, Hospital of Montpellier, Montpellier, France; Equipe EPAR - IPLESP, UMR 1136 INSERM - Sorbonne Université, Paris, France.
² KU Leuven Department of Microbiology and Clinical Immunology, Laboratory of Clinical Immunology, Leuven, Belgium.
³ Department of Pulmonology, Division of Allergy, Hôpital Arnaud de Villeneuve, University, Hospital of Montpellier, Montpellier, France.
⁴ Department of Pulmonology, Division of Allergy, Hôpital Arnaud de Villeneuve, University, Hospital of Montpellier, Montpellier, France; Department of Clinical Pharmacology, University Hospital of Fattouma Bourguiba, Monastir, Tunisia.
⁵ Department of Pulmonology, Division of Allergy, Hôpital Arnaud de Villeneuve, University, Hospital of Montpellier, Montpellier, France; Equipe EPAR - IPLESP, UMR 1136 INSERM - Sorbonne Université, Paris, France. Electronic address: [email protected].

No abstract available

Publication types